Xeris Biopharma Holdings, Inc. (XERS) compared with its closest peers (RIGL, IRWD, CRMD, LGND, SDGR). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Rigel Pharmaceuticals, Ironwood Pharmaceuticals, CorMedix, Ligand Pharmaceuticals, Schrödinger, Arcus Biosciences, Keros Therapeutics, Atea Pharmaceuticals, Akebia Therapeutics and AnaptysBio share Xeris Biopharma's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Rigel Pharmaceuticals, Inc. (RIGL) | $857.22M | 13.7 |
| Ironwood Pharmaceuticals, Inc. (IRWD) | $708.05M | 4.1 |
| CorMedix Inc. (CRMD) | $638.36M | 3.4 |
| Ligand Pharmaceuticals Incorporated (LGND) | $5.70B | 41.0 |
| Schrödinger, Inc. (SDGR) | $1.46B | -12.7 |
| Arcus Biosciences, Inc. (RCUS) | $3.82B | -7.2 |
| Keros Therapeutics, Inc. (KROS) | $219.29M | 8.8 |
| Atea Pharmaceuticals, Inc. (AVIR) | $434.71M | -1.8 |
| Akebia Therapeutics, Inc. (AKBA) | $243.63M | -80.3 |
| AnaptysBio, Inc. (ANAB) | $1.68B | -105.4 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
XERS overview · XERS earnings · XERS financials · XERS KPIs · XERS documents · XERS ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.